trial · primary record
LYB005
Respiratory Syncytial Virus (RSV)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 25000 |
| Primary completion | 2027-12 |
| Primary endpoint | Incidence of first episode of RSV-associated lower respiratory tract disease (RSV-LRTD) from 14 days post-vaccination through the end of the first RSV season |
| Registry ID | NCT07908654 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:09.475Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908654
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.